不安障害治療の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Anxiety Disorders Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-14760 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、122ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、不安障害治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。不安障害治療の種類別市場規模（自己治療、精神治療、薬）、用途別市場規模（大うつ病性障害（MDD）、強迫性障害（OCD）、恐怖症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Limbix、Pear Therapeutics、Omada Health、DarioHealth、Akili Interactive、Holmusk、Quartet Health、Click Therapeutics、Express Scripts、Iora Health、Akili Interactive Labs、Lyra Health、AbleTo、Medsphere Systems、Headspace、Ginger.io、Happify、Rivermend Health、Joyable ・地域別グローバル市場分析 2015年-2020年 ・不安障害治療の北米市場（アメリカ、カナダ、メキシコ） ・不安障害治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・不安障害治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・不安障害治療の南米市場（ブラジル、アルゼンチン） ・不安障害治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：自己治療、精神治療、薬 ・用途別分析：大うつ病性障害（MDD）、強迫性障害（OCD）、恐怖症、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The Anxiety Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Anxiety Disorders Treatment sales will be xx in 2020 from Anxiety Disorders Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Anxiety Disorders Treatment market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Anxiety Disorders Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Anxiety Disorders Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Anxiety Disorders Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Anxiety Disorders Treatment market has been segmented into:
Self-treatment
Psy-treatment
Medications

By Application, Anxiety Disorders Treatment has been segmented into:
Major Depressive Disorder (MDD)
Obsessive-Compulsive Disorder (OCD)
Phobia
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anxiety Disorders Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Anxiety Disorders Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anxiety Disorders Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Anxiety Disorders Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Anxiety Disorders Treatment Market Share Analysis
Anxiety Disorders Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anxiety Disorders Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anxiety Disorders Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Anxiety Disorders Treatment are:
Limbix
Pear Therapeutics
Omada Health
DarioHealth
Akili Interactive
Holmusk
Quartet Health
Click Therapeutics
Express Scripts
Iora Health
Akili Interactive Labs
Lyra Health
AbleTo
Medsphere Systems
Headspace
Ginger.io
Happify
Rivermend Health
Joyable

レポート目次

---

1 Anxiety Disorders Treatment Market Overview
1.1 Product Overview and Scope of Anxiety Disorders Treatment
1.2 Classification of Anxiety Disorders Treatment by Type
1.2.1 Global Anxiety Disorders Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anxiety Disorders Treatment Revenue Market Share by Type in 2019
1.2.3 Self-treatment
1.2.4 Psy-treatment
1.2.5 Medications
1.3 Global Anxiety Disorders Treatment Market by Application
1.3.1 Overview: Global Anxiety Disorders Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Major Depressive Disorder (MDD)
1.3.3 Obsessive-Compulsive Disorder (OCD)
1.3.4 Phobia
1.3.5 Others
1.4 Global Anxiety Disorders Treatment Market by Regions
1.4.1 Global Anxiety Disorders Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anxiety Disorders Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anxiety Disorders Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anxiety Disorders Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anxiety Disorders Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anxiety Disorders Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anxiety Disorders Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Anxiety Disorders Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the Anxiety Disorders Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Anxiety Disorders Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Limbix
2.1.1 Limbix Details
2.1.2 Limbix Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Limbix SWOT Analysis
2.1.4 Limbix Product and Services
2.1.5 Limbix Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pear Therapeutics
2.2.1 Pear Therapeutics Details
2.2.2 Pear Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pear Therapeutics SWOT Analysis
2.2.4 Pear Therapeutics Product and Services
2.2.5 Pear Therapeutics Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Omada Health
2.3.1 Omada Health Details
2.3.2 Omada Health Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Omada Health SWOT Analysis
2.3.4 Omada Health Product and Services
2.3.5 Omada Health Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 DarioHealth
2.4.1 DarioHealth Details
2.4.2 DarioHealth Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 DarioHealth SWOT Analysis
2.4.4 DarioHealth Product and Services
2.4.5 DarioHealth Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Akili Interactive
2.5.1 Akili Interactive Details
2.5.2 Akili Interactive Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Akili Interactive SWOT Analysis
2.5.4 Akili Interactive Product and Services
2.5.5 Akili Interactive Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Holmusk
2.6.1 Holmusk Details
2.6.2 Holmusk Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Holmusk SWOT Analysis
2.6.4 Holmusk Product and Services
2.6.5 Holmusk Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Quartet Health
2.7.1 Quartet Health Details
2.7.2 Quartet Health Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Quartet Health SWOT Analysis
2.7.4 Quartet Health Product and Services
2.7.5 Quartet Health Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Click Therapeutics
2.8.1 Click Therapeutics Details
2.8.2 Click Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Click Therapeutics SWOT Analysis
2.8.4 Click Therapeutics Product and Services
2.8.5 Click Therapeutics Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Express Scripts
2.9.1 Express Scripts Details
2.9.2 Express Scripts Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Express Scripts SWOT Analysis
2.9.4 Express Scripts Product and Services
2.9.5 Express Scripts Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Iora Health
2.10.1 Iora Health Details
2.10.2 Iora Health Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Iora Health SWOT Analysis
2.10.4 Iora Health Product and Services
2.10.5 Iora Health Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Akili Interactive Labs
2.11.1 Akili Interactive Labs Details
2.11.2 Akili Interactive Labs Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Akili Interactive Labs SWOT Analysis
2.11.4 Akili Interactive Labs Product and Services
2.11.5 Akili Interactive Labs Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Lyra Health
2.12.1 Lyra Health Details
2.12.2 Lyra Health Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Lyra Health SWOT Analysis
2.12.4 Lyra Health Product and Services
2.12.5 Lyra Health Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 AbleTo
2.13.1 AbleTo Details
2.13.2 AbleTo Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 AbleTo SWOT Analysis
2.13.4 AbleTo Product and Services
2.13.5 AbleTo Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Medsphere Systems
2.14.1 Medsphere Systems Details
2.14.2 Medsphere Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Medsphere Systems SWOT Analysis
2.14.4 Medsphere Systems Product and Services
2.14.5 Medsphere Systems Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Headspace
2.15.1 Headspace Details
2.15.2 Headspace Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Headspace SWOT Analysis
2.15.4 Headspace Product and Services
2.15.5 Headspace Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Ginger.io
2.16.1 Ginger.io Details
2.16.2 Ginger.io Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Ginger.io SWOT Analysis
2.16.4 Ginger.io Product and Services
2.16.5 Ginger.io Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Happify
2.17.1 Happify Details
2.17.2 Happify Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Happify SWOT Analysis
2.17.4 Happify Product and Services
2.17.5 Happify Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Rivermend Health
2.18.1 Rivermend Health Details
2.18.2 Rivermend Health Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Rivermend Health SWOT Analysis
2.18.4 Rivermend Health Product and Services
2.18.3 Rivermend Health Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Joyable
2.19.1 Joyable Details
2.19.2 Joyable Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Joyable SWOT Analysis
2.19.4 Joyable Product and Services
2.19.5 Joyable Anxiety Disorders Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anxiety Disorders Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anxiety Disorders Treatment Players Market Share
3.2.2 Top 10 Anxiety Disorders Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anxiety Disorders Treatment Revenue and Market Share by Regions
4.2 North America Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
5 North America Anxiety Disorders Treatment Revenue by Countries
5.1 North America Anxiety Disorders Treatment Revenue by Countries (2015-2020)
5.2 USA Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
6 Europe Anxiety Disorders Treatment Revenue by Countries
6.1 Europe Anxiety Disorders Treatment Revenue by Countries (2015-2020)
6.2 Germany Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
6.4 France Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anxiety Disorders Treatment Revenue by Countries
7.1 Asia-Pacific Anxiety Disorders Treatment Revenue by Countries (2015-2020)
7.2 China Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
7.5 India Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
8 South America Anxiety Disorders Treatment Revenue by Countries
8.1 South America Anxiety Disorders Treatment Revenue by Countries (2015-2020)
8.2 Brazil Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anxiety Disorders Treatment by Countries
9.1 Middle East & Africa Anxiety Disorders Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anxiety Disorders Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Anxiety Disorders Treatment Market Forecast by Type (2019-2024)
10.3 Self-treatment Revenue Growth Rate (2015-2025)
10.4 Psy-treatment Revenue Growth Rate (2015-2025)
10.5 Medications Revenue Growth Rate (2015-2025)
11 Global Anxiety Disorders Treatment Market Segment by Application
11.1 Global Anxiety Disorders Treatment Revenue Market Share by Application (2015-2020)
11.2 Anxiety Disorders Treatment Market Forecast by Application (2019-2024)
11.3 Major Depressive Disorder (MDD) Revenue Growth (2015-2020)
11.4 Obsessive-Compulsive Disorder (OCD) Revenue Growth (2015-2020)
11.5 Phobia Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Anxiety Disorders Treatment Market Size Forecast (2021-2025)
12.1 Global Anxiety Disorders Treatment Market Size Forecast (2021-2025)
12.2 Global Anxiety Disorders Treatment Market Forecast by Regions (2021-2025)
12.3 North America Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
12.6 South America Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Anxiety Disorders Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anxiety Disorders Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anxiety Disorders Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anxiety Disorders Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Anxiety Disorders Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Limbix Corporate Information, Location and Competitors
Table 7. Limbix Anxiety Disorders Treatment Major Business
Table 8. Limbix Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Limbix SWOT Analysis
Table 10. Limbix Anxiety Disorders Treatment Product and Solutions
Table 11. Limbix Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Pear Therapeutics Corporate Information, Location and Competitors
Table 13. Pear Therapeutics Anxiety Disorders Treatment Major Business
Table 14. Pear Therapeutics Anxiety Disorders Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Pear Therapeutics SWOT Analysis
Table 16. Pear Therapeutics Anxiety Disorders Treatment Product and Solutions
Table 17. Pear Therapeutics Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Omada Health Corporate Information, Location and Competitors
Table 19. Omada Health Anxiety Disorders Treatment Major Business
Table 20. Omada Health Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Omada Health SWOT Analysis
Table 22. Omada Health Anxiety Disorders Treatment Product and Solutions
Table 23. Omada Health Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. DarioHealth Corporate Information, Location and Competitors
Table 25. DarioHealth Anxiety Disorders Treatment Major Business
Table 26. DarioHealth Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 27. DarioHealth SWOT Analysis
Table 28. DarioHealth Anxiety Disorders Treatment Product and Solutions
Table 29. DarioHealth Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Akili Interactive Corporate Information, Location and Competitors
Table 31. Akili Interactive Anxiety Disorders Treatment Major Business
Table 32. Akili Interactive Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Akili Interactive SWOT Analysis
Table 34. Akili Interactive Anxiety Disorders Treatment Product and Solutions
Table 35. Akili Interactive Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Holmusk Corporate Information, Location and Competitors
Table 37. Holmusk Anxiety Disorders Treatment Major Business
Table 38. Holmusk Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Holmusk SWOT Analysis
Table 40. Holmusk Anxiety Disorders Treatment Product and Solutions
Table 41. Holmusk Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Quartet Health Corporate Information, Location and Competitors
Table 43. Quartet Health Anxiety Disorders Treatment Major Business
Table 44. Quartet Health Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 45. Quartet Health SWOT Analysis
Table 46. Quartet Health Anxiety Disorders Treatment Product and Solutions
Table 47. Quartet Health Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Click Therapeutics Corporate Information, Location and Competitors
Table 49. Click Therapeutics Anxiety Disorders Treatment Major Business
Table 50. Click Therapeutics Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Click Therapeutics SWOT Analysis
Table 52. Click Therapeutics Anxiety Disorders Treatment Product and Solutions
Table 53. Click Therapeutics Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Express Scripts Corporate Information, Location and Competitors
Table 55. Express Scripts Anxiety Disorders Treatment Major Business
Table 56. Express Scripts Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Express Scripts SWOT Analysis
Table 58. Express Scripts Anxiety Disorders Treatment Product and Solutions
Table 59. Express Scripts Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Iora Health Corporate Information, Location and Competitors
Table 61. Iora Health Anxiety Disorders Treatment Major Business
Table 62. Iora Health Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Iora Health SWOT Analysis
Table 64. Iora Health Anxiety Disorders Treatment Product and Solutions
Table 65. Iora Health Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Akili Interactive Labs Corporate Information, Location and Competitors
Table 67. Akili Interactive Labs Anxiety Disorders Treatment Major Business
Table 68. Akili Interactive Labs Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 69. Akili Interactive Labs SWOT Analysis
Table 70. Akili Interactive Labs Anxiety Disorders Treatment Product and Solutions
Table 71. Akili Interactive Labs Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Lyra Health Corporate Information, Location and Competitors
Table 73. Lyra Health Anxiety Disorders Treatment Major Business
Table 74. Lyra Health Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 75. Lyra Health SWOT Analysis
Table 76. Lyra Health Anxiety Disorders Treatment Product and Solutions
Table 77. Lyra Health Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. AbleTo Corporate Information, Location and Competitors
Table 79. AbleTo Anxiety Disorders Treatment Major Business
Table 80. AbleTo Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 81. AbleTo SWOT Analysis
Table 82. AbleTo Anxiety Disorders Treatment Product and Solutions
Table 83. AbleTo Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Medsphere Systems Corporate Information, Location and Competitors
Table 85. Medsphere Systems Anxiety Disorders Treatment Major Business
Table 86. Medsphere Systems Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 87. Medsphere Systems SWOT Analysis
Table 88. Medsphere Systems Anxiety Disorders Treatment Product and Solutions
Table 89. Medsphere Systems Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Headspace Corporate Information, Location and Competitors
Table 91. Headspace Anxiety Disorders Treatment Major Business
Table 92. Headspace Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 93. Headspace SWOT Analysis
Table 94. Headspace Anxiety Disorders Treatment Product and Solutions
Table 95. Headspace Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Ginger.io Corporate Information, Location and Competitors
Table 97. Ginger.io Anxiety Disorders Treatment Major Business
Table 98. Ginger.io Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 99. Ginger.io SWOT Analysis
Table 100. Ginger.io Anxiety Disorders Treatment Product and Solutions
Table 101. Ginger.io Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Happify Corporate Information, Location and Competitors
Table 103. Happify Anxiety Disorders Treatment Major Business
Table 104. Happify Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 105. Happify SWOT Analysis
Table 106. Happify Anxiety Disorders Treatment Product and Solutions
Table 107. Happify Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Rivermend Health Anxiety Disorders Treatment Type and Application
Table 109. Rivermend Health Anxiety Disorders Treatment Major Business
Table 110. Rivermend Health Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 111. Rivermend Health SWOT Analysis
Table 112. Rivermend Health Anxiety Disorders Treatment Product and Solutions
Table 113. Rivermend Health Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Joyable Corporate Information, Location and Competitors
Table 115. Joyable Anxiety Disorders Treatment Major Business
Table 116. Joyable Anxiety Disorders Treatment Total Revenue (USD Million) (2017-2018)
Table 117. Joyable SWOT Analysis
Table 118. Joyable Anxiety Disorders Treatment Product and Solutions
Table 119. Joyable Anxiety Disorders Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Global Anxiety Disorders Treatment Revenue (Million USD) by Players (2015-2020)
Table 121. Global Anxiety Disorders Treatment Revenue Share by Players (2015-2020)
Table 122. Global Anxiety Disorders Treatment Revenue (Million USD) by Regions (2015-2020)
Table 123. Global Anxiety Disorders Treatment Revenue Market Share by Regions (2015-2020)
Table 124. North America Anxiety Disorders Treatment Revenue by Countries (2015-2020)
Table 125. North America Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 126. Europe Anxiety Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 127. Asia-Pacific Anxiety Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 128. South America Anxiety Disorders Treatment Revenue by Countries (2015-2020)
Table 129. South America Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 130. Middle East and Africa Anxiety Disorders Treatment Revenue (Million USD) by Countries (2015-2020)
Table 131. Middle East and Africa Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Table 132. Global Anxiety Disorders Treatment Revenue (Million USD) by Type (2015-2020)
Table 133. Global Anxiety Disorders Treatment Revenue Share by Type (2015-2020)
Table 134. Global Anxiety Disorders Treatment Revenue Forecast by Type (2021-2025)
Table 135. Global Anxiety Disorders Treatment Revenue by Application (2015-2020)
Table 136. Global Anxiety Disorders Treatment Revenue Share by Application (2015-2020)
Table 137. Global Anxiety Disorders Treatment Revenue Forecast by Application (2021-2025)
Table 138. Global Anxiety Disorders Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anxiety Disorders Treatment Picture
Figure 2. Global Anxiety Disorders Treatment Revenue Market Share by Type in 2019
Figure 3. Self-treatment Picture
Figure 4. Psy-treatment Picture
Figure 5. Medications Picture
Figure 6. Anxiety Disorders Treatment Revenue Market Share by Application in 2019
Figure 7. Major Depressive Disorder (MDD) Picture
Figure 8. Obsessive-Compulsive Disorder (OCD) Picture
Figure 9. Phobia Picture
Figure 10. Others Picture
Figure 11. Global Anxiety Disorders Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Anxiety Disorders Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Anxiety Disorders Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players Anxiety Disorders Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Anxiety Disorders Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global Anxiety Disorders Treatment Revenue Market Share by Regions in 2018
Figure 25. North America Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America Anxiety Disorders Treatment Revenue Market Share by Countries in 2019
Figure 32. USA Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Anxiety Disorders Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Anxiety Disorders Treatment Revenue Market Share by Countries in 2019
Figure 44. China Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America Anxiety Disorders Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Anxiety Disorders Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Anxiety Disorders Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Anxiety Disorders Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global Anxiety Disorders Treatment Revenue Share by Type (2015-2020)
Figure 60. Global Anxiety Disorders Treatment Revenue Share by Type in 2019
Figure 61. Global Anxiety Disorders Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Self-treatment Revenue Growth Rate (2015-2020)
Figure 63. Global Psy-treatment Revenue Growth Rate (2015-2020)
Figure 64. Global Medications Revenue Growth Rate (2015-2020)
Figure 65. Global Anxiety Disorders Treatment Revenue Share by Application (2015-2020)
Figure 66. Global Anxiety Disorders Treatment Revenue Share by Application in 2019
Figure 67. Global Anxiety Disorders Treatment Market Share Forecast by Application (2021-2025)
Figure 68. Global Major Depressive Disorder (MDD) Revenue Growth Rate (2015-2020)
Figure 69. Global Obsessive-Compulsive Disorder (OCD) Revenue Growth Rate (2015-2020)
Figure 70. Global Phobia Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Anxiety Disorders Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Anxiety Disorders Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Anxiety Disorders Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Anxiety Disorders Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---